Home » Newsletters » BioWorld Science

BioWorld Science

July 3, 2013

View Archived Issues

Janssen and J&J announce research alliance with the Icahn School of Medicine

Seattle Genetics and Agensys set to develop additional antibody-drug conjugate

Information and data on numerous nivolumab clinical trials presented

Immune Design and Medicago collaborate on novel pandemic influenza vaccine development

Islet Sciences' chief scientific officer receives grant from JDRF

A novel anti-inflammatory fusion protein inhibits chronic inflammatory and neuropathic pain in vivo

Resverlogix reports topline data from the ASSURE trial

Soligenix completes phase I study of SGX-203 for pediatric Crohn's disease

[18F]-PR-04.MZ evaluated for dopamine transporter quantification in humans

Central venous thrombosis recurrence linked to JAK2 gene V617F mutation

EMA gives Provenge a positive opinion

Procysbi receives positive CHMP recommendation

FDA approves first nonhormonal therapy for menopause-related vasomotor symptoms

Researchers in Portugal patent novel agents for the treatment of tuberculosis

Janssen Pharmaceutica divulges new stearoyl-CoA desaturase inhibitors

FDA approves Latuda as monotherapy and adjunctive therapy for bipolar depression

Fresenius divests biotech business

Bayer patents new Mnk1 inhibitors

Janssen presents bioequivalence results for darunavir/cobicistat fixed-drug combination

AV-0113 receives FDA orphan drug designation

German and Saudi researchers present novel vaccines

NeuroMax signs license agreement with Aquilus Pharmaceuticals for AQU-005

New histamine H3 receptor antagonists disclosed by Taisho Pharmaceutical

Emergent BioSolutions receives approval for BioThrax in Germany

EMA approves positive opinion on Omeros' pediatric investigation plan

FDA accepts NDA filing for cangrelor

Novartis seeks approval of ELC-200 in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026